Archive: 05/06/2015

FDA weighs approval of first-in-class cholesterol drug

Federal health regulators said Friday that a highly-anticipated, experimental drug from Sanofi lowers bad cholesterol more than older drugs. But officials have questions about whether to approve the drug based on that measure ...

page 3 from 6